Danaher Corp. (DHR)
207.66
-3.37
(-1.60%)
USD |
NYSE |
Sep 04, 16:00
207.60
-0.06
(-0.03%)
After-Hours: 20:00
Danaher Research and Development Expense (Quarterly) : 412.00M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 412.00M |
| March 31, 2026 | 387.00M |
| December 31, 2025 | 438.00M |
| September 30, 2025 | 378.00M |
| June 30, 2025 | 403.00M |
| March 31, 2025 | 379.00M |
| December 31, 2024 | 442.00M |
| September 30, 2024 | 383.00M |
| June 30, 2024 | 391.00M |
| March 31, 2024 | 368.00M |
| December 31, 2023 | 407.00M |
| September 30, 2023 | 362.00M |
| June 30, 2023 | 418.00M |
| March 31, 2023 | 373.00M |
| December 31, 2022 | 400.00M |
| September 30, 2022 | 420.00M |
| June 30, 2022 | 431.00M |
| March 31, 2022 | 441.00M |
| December 31, 2021 | 495.00M |
| September 30, 2021 | 441.00M |
| June 30, 2021 | 426.00M |
| March 31, 2021 | 380.00M |
| December 31, 2020 | 396.00M |
| September 30, 2020 | 342.60M |
| June 30, 2020 | 322.60M |
| Date | Value |
|---|---|
| March 31, 2020 | 287.00M |
| December 31, 2019 | 293.80M |
| September 30, 2019 | 282.60M |
| June 30, 2019 | 282.10M |
| March 31, 2019 | 267.50M |
| December 31, 2018 | 276.00M |
| September 30, 2018 | 301.20M |
| June 30, 2018 | 311.70M |
| March 31, 2018 | 298.70M |
| December 31, 2017 | 298.90M |
| September 30, 2017 | 279.20M |
| June 30, 2017 | 283.30M |
| March 31, 2017 | 267.40M |
| December 31, 2016 | 268.00M |
| September 30, 2016 | 241.10M |
| June 30, 2016 | 239.90M |
| March 31, 2016 | 226.10M |
| December 31, 2015 | 327.10M |
| September 30, 2015 | 307.90M |
| June 30, 2015 | 344.90M |
| March 31, 2015 | 339.10M |
| December 31, 2014 | 336.10M |
| September 30, 2014 | 328.30M |
| June 30, 2014 | 336.40M |
| March 31, 2014 | 313.40M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 120.00M |
| Thermo Fisher Scientific, Inc. | 364.00M |
| Illumina, Inc. | 257.00M |
| Waters Corp. | 121.00M |
| Bio-Rad Laboratories, Inc. | 61.20M |